New implant coating "dramatically" lowers inflammation
This article was originally published in Clinica
Executive Summary
MetaPhore Pharmaceuticals says that a study has shown that treating the surface of implanted biomaterials with the company's anti-inflammatory agents leads to a "dramatic" reduction in inflammation around the implants.